Metabolism of ether phospholipids and analogs in neoplastic cells.
The ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (OM-GPC) is known to be a potent inhibitor of cell growth. Metabolic studies in both Raji and L1210 leukemic cells on OM-GPC, 3H-labeled in the methyl groups of the choline moiety, showed a (diacyl)-phosphatidylcholine as the only labeled metabolite. Since the formation of radiolabeled (diacyl)-phosphatidylcholine showed a direct correlation with cell death, we tested other lipid analogs. One of these compounds, hexadecylphosphocholine (He-PC), which was 3H-labeled in the methyl-choline groups, showed a formation of labeled (diacyl)-phosphatidylcholine similar to that found with OM-GPC. Again, there was a direct linear correlation between the formation of the labeled product and cell death. He-PC was found to be a potent cell toxin in in vitro experiments on cell cultures. However, analogs with an elongated phosphor to trimethylammonium distance showed no toxicity towards the cells in in vitro experiments. From the data, we conclude that the ether phospholipids are substrates for a phospholipase C or related enzyme. This substrate property may be responsible for the toxicity of the compounds in neoplastic cells.
Fleer
E A
EA
Max-Planck-Institut für biophysikalische Chemie, Abt. 140, Am Fassberg, Goettingen.
Unger
C
C
Kim
D J
DJ
Eibl
H
H
D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D010713:Phosphatidylcholines / Q000378:metabolism; D010742:Phospholipid Ethers / Q000493:pharmacokinetics* / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism*
D010713:Phosphatidylcholines; D010742:Phospholipid Ethers; C026659:edelfosine